MedPath

Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781]

Terminated
Conditions
Esophageal Cancer
Registration Number
NCT00003381
Lead Sponsor
Alliance for Clinical Trials in Oncology
Brief Summary

RATIONALE: Questionnaires that measure quality of life during treatment may improve the ability to plan treatment for patients with esophageal cancer.

PURPOSE: This clinical trial is studying the quality of life in patients receiving treatment for esophageal cancer.

Detailed Description

OBJECTIVES: I. Evaluate the quality of life of patients with esophageal cancer randomized on protocol CALGB C9781 to treatment with surgery alone vs trimodal therapy combining preoperative chemotherapy and radiation therapy in addition to surgery. II. Examine the incremental cost and cost effectiveness of preoperative chemotherapy and radiation therapy in the treatment of esophageal cancer. III. Examine the incremental cost per quality-adjusted life year (QALY) of preoperative chemotherapy and radiation therapy in the treatment of esophageal cancer.

OUTLINE: This is a companion study to CALGB C9781, a phase III randomized study. Prior to treatment on CALGB C9781, patients complete forms assessing quality of life, psychological functioning, specific areas of dysfunction, resource use, and time lost from work; subsequent assessments are completed by telephone interview at 1, 2, 6, 12, 18, and 24 months after the initiation of study treatment, regardless of disease status (patients with hearing impairment and those speaking only a translatable foreign language may mail responses). Patients also keep a diary of medical resource utilization at sites other than the treating institution.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
56
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluate the quality of life of patientsUp to 3 years post treatment
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (44)

Veterans Affairs Medical Center - Birmingham

🇺🇸

Birmingham, Alabama, United States

University of California San Diego Cancer Center

🇺🇸

La Jolla, California, United States

UCSF Cancer Center and Cancer Research Institute

🇺🇸

San Francisco, California, United States

Veterans Affairs Medical Center - San Francisco

🇺🇸

San Francisco, California, United States

CCOP - Christiana Care Health Services

🇺🇸

Wilmington, Delaware, United States

Walter Reed Army Medical Center

🇺🇸

Washington, District of Columbia, United States

CCOP - Mount Sinai Medical Center

🇺🇸

Miami Beach, Florida, United States

University of Illinois at Chicago Health Sciences Center

🇺🇸

Chicago, Illinois, United States

Veterans Affairs Medical Center - Chicago (Westside Hospital)

🇺🇸

Chicago, Illinois, United States

University of Chicago Cancer Research Center

🇺🇸

Chicago, Illinois, United States

Scroll for more (34 remaining)
Veterans Affairs Medical Center - Birmingham
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.